Invention Grant
- Patent Title: Adapted lepidopteran insect cells for the production of recombinant proteins
-
Application No.: US14775154Application Date: 2014-03-13
-
Publication No.: US09611455B2Publication Date: 2017-04-04
- Inventor: James M. Wagner , Shyamsundar Subramanian , David Pajerowski
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Henry P. Wu; Gloria M. Fuentes
- International Application: PCT/US2014/025277 WO 20140313
- International Announcement: WO2014/159831 WO 20141002
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/07 ; C07K14/005 ; C12N7/00 ; C12P21/00

Abstract:
The present invention relates to the use of increased culture pH, relative to standard insect cell culture conditions, during baculovirus infection of lepidopteran insect cells to enable production of recombinant chikungunya (CHIKV) virus like particles (VLPs). The invention further relates to adapted insect cell lines derived from insect cells such as Sf21, which can grow robustly at elevated culture pH, the use of said cell lines to recombinantly produce pH sensitive proteins in the correct conformation and increase expression of recombinant proteins relative to standard insect cell lines. In some embodiments of the invention, the cells are useful for recombinant production of CHIKV VLPs. The invention also relates to a method for the production of a pH-adapted lepidopteran insect cell line. In some embodiments of said method, the cell line is produced and/or maintained in reduced phosphate serum-free insect cell media.
Public/Granted literature
- US20160040124A1 ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS Public/Granted day:2016-02-11
Information query